Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSI 136 Administered Orally to Healthy Young and Healthy Elderly Subjects.
Phase of Trial: Phase I
Latest Information Update: 07 Apr 2010
At a glance
- Drugs GSI 136 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 07 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Aug 2008 New trial record.